AT410753B - Pibf für die diagnose von tumoren - Google Patents

Pibf für die diagnose von tumoren Download PDF

Info

Publication number
AT410753B
AT410753B AT0199700A AT19972000A AT410753B AT 410753 B AT410753 B AT 410753B AT 0199700 A AT0199700 A AT 0199700A AT 19972000 A AT19972000 A AT 19972000A AT 410753 B AT410753 B AT 410753B
Authority
AT
Austria
Prior art keywords
pibf
sep
glu
leu
fragment
Prior art date
Application number
AT0199700A
Other languages
German (de)
English (en)
Other versions
ATA19972000A (de
Original Assignee
Biodevelops Verwertung Von Liz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AT0199700A priority Critical patent/AT410753B/de
Application filed by Biodevelops Verwertung Von Liz filed Critical Biodevelops Verwertung Von Liz
Priority to AU2490102A priority patent/AU2490102A/xx
Priority to AU2002224901A priority patent/AU2002224901B2/en
Priority to JP2002546225A priority patent/JP4025645B2/ja
Priority to DE60127442T priority patent/DE60127442T2/de
Priority to CA002431837A priority patent/CA2431837A1/en
Priority to ES01994744T priority patent/ES2283461T3/es
Priority to PCT/EP2001/013876 priority patent/WO2002044734A1/en
Priority to EP01994744A priority patent/EP1337850B1/en
Priority to AT01994744T priority patent/ATE357662T1/de
Publication of ATA19972000A publication Critical patent/ATA19972000A/de
Priority to US10/444,693 priority patent/US20040142394A1/en
Application granted granted Critical
Publication of AT410753B publication Critical patent/AT410753B/de
Priority to JP2006043156A priority patent/JP2006230407A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT0199700A 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren AT410753B (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren
EP01994744A EP1337850B1 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf
JP2002546225A JP4025645B2 (ja) 2000-11-28 2001-11-28 Ｐｉｂｆ濃度測定によるガン患者の検査方法
DE60127442T DE60127442T2 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten
CA002431837A CA2431837A1 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf
ES01994744T ES2283461T3 (es) 2000-11-28 2001-11-28 Procedimiento para diagnosticar un tumor en un paciente determinando la concentracion de pibf.
AU2490102A AU2490102A (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf
AU2002224901A AU2002224901B2 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of PIBF
AT01994744T ATE357662T1 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten
PCT/EP2001/013876 WO2002044734A1 (en) 2000-11-28 2001-11-28 Method for diagnosing a tumor in a patient determining the concentration of pibf
US10/444,693 US20040142394A1 (en) 2000-11-28 2003-05-23 Method for diagnosing a tumor in a patient determining the concentration of PIBF
JP2006043156A JP2006230407A (ja) 2000-11-28 2006-02-20 Ｐｉｂｆ活性をもつタンパク質及びこれをコードする核酸分子

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren

Publications (2)

Publication Number Publication Date
ATA19972000A ATA19972000A (de) 2002-12-15
AT410753B true AT410753B (de) 2003-07-25

Family

ID=3689570

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren
AT01994744T ATE357662T1 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT01994744T ATE357662T1 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten

Country Status (9)

Country Link
US (1) US20040142394A1 (enExample)
EP (1) EP1337850B1 (enExample)
JP (2) JP4025645B2 (enExample)
AT (2) AT410753B (enExample)
AU (2) AU2002224901B2 (enExample)
CA (1) CA2431837A1 (enExample)
DE (1) DE60127442T2 (enExample)
ES (1) ES2283461T3 (enExample)
WO (1) WO2002044734A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA8092002A (de) * 2002-05-28 2005-01-15 Intercell Ag Pibf
JP2015109806A (ja) * 2012-03-22 2015-06-18 アステラス製薬株式会社 新規ｒｅｔ融合体の検出法
GB201702392D0 (en) * 2017-02-14 2017-03-29 Univ Edinburgh Methods for cancer diagnosis using a gene expression signature
CN108447537A (zh) * 2018-03-23 2018-08-24 广西科技大学 一种妊娠期及哺乳期妇女用药安全和健康管理系统
KR102490714B1 (ko) * 2018-12-28 2023-01-26 재단법인 아산사회복지재단 Pibf 단백질을 유효성분으로 함유하는 염증성 질환 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648340A (en) * 1991-10-31 1997-07-15 Barnea; Eytan R. Gestational agents for controlling cell proliferation
US5646003A (en) * 1994-03-23 1997-07-08 Barnea; Eytan R. Preimplantation factor
US6207380B1 (en) * 1997-09-15 2001-03-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
IL140625A0 (en) * 1998-07-02 2002-02-10 Envision Biomedical Consulting Antiproliferative and antiviral proteins and peptides
AU7854400A (en) * 1999-10-08 2001-04-23 Envision Biomedical Consulting Gestational agents which modulate cell proliferation

Also Published As

Publication number Publication date
DE60127442D1 (de) 2007-05-03
AU2490102A (en) 2002-06-11
ATA19972000A (de) 2002-12-15
JP4025645B2 (ja) 2007-12-26
JP2006230407A (ja) 2006-09-07
ATE357662T1 (de) 2007-04-15
CA2431837A1 (en) 2002-06-06
AU2002224901B2 (en) 2006-11-09
DE60127442T2 (de) 2007-11-29
US20040142394A1 (en) 2004-07-22
EP1337850B1 (en) 2007-03-21
ES2283461T3 (es) 2007-11-01
EP1337850A1 (en) 2003-08-27
WO2002044734A1 (en) 2002-06-06
JP2004514909A (ja) 2004-05-20

Similar Documents

Publication Publication Date Title
DE69735375T2 (de) Genfamilie von apoptose-verwandten peptiden, dadurch kodierte peptide und verfahren zu deren herstellung
DE69334186T2 (de) Vom MAGE-3-Gen en abgeleitetes und von HLA-A1 präsentiertes, isoliertes Nonapeptid und dessen Anwendungen
EP2314610B1 (de) Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
TW201307385A (zh) 胃腸炎症和銀屑病以及哮喘的治療
DE69931482T2 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
EP2327721B1 (de) Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
KR102033215B1 (ko) 건선 유발 동물 모델 및 이의 용도
AT410753B (de) Pibf für die diagnose von tumoren
EP1423425B1 (de) Rezeptor, dessen verwendung sowie mausantikörper
EP1529060B1 (de) Verfahren zur herstellung eines immunstimulatorischen muzins (muc1)
Iborra et al. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells
US20080187530A1 (en) Novel Agents and Use Thereof
WO2003100428A2 (de) Verfahren zu diagnostizierung eines tumors bei einem patienten durch bestimmung von pibf
DE69737570T2 (de) Agentien zur präsymptomatischen Detektion, Prävention und Behandlung von Brustkrebs in Menschen
EP1386615B1 (de) EG-VEGF/Prokineticin 2 Rezeptor Antagonisten
AU2002224901A1 (en) Method for diagnosing a tumor in a patient determining the concentration of PIBF
CN113398270A (zh) 一种治疗骨巨细胞瘤的方法
Hanocq‐quertier et al. Expression of ras‐like proteins in embryonic and adult cells of Xenopus laevis
Quaynor The Function of NELF and ESR1 in puberty development and fertility
DE10210425A1 (de) Rezeptor, dessen Verwendung sowie Mausantikörper
DE10136009A1 (de) Rezeptor, dessen Verwendung sowie Mausantikörper

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee